Drug-price Transparency in Communications (DTC) Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Drug-price Transparency in Communications (DTC) Act
This bill provides statutory authority for the Centers for Medicare & Medicaid Services rule titled Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency, published on May 10, 2019. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule takes effect July 9, 2019.
Read twice and referred to the Committee on Finance. (text: CR S2791)
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 1437: Drug-price Transparency in Communications (DTC) Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-1437/
"S. 1437: Drug-price Transparency in Communications (DTC) Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-1437/.
S. 1437, 116th Cong. (2026), https://openamerica.io/bill/116-S-1437/.
[S. 1437: Drug-price Transparency in Communications (DTC) Act](https://openamerica.io/bill/116-S-1437/)